Company Valuation: Molecule Group plc

Data adjusted to current consolidation scope
Fiscal Period: December 2026 2027 2028
Market Cap 1 55.64 - -
Change - - -
Enterprise Value (EV) 1 51.34 49.99 48.19
Change - -2.63% -3.6%
P/E -7.58x -31.1x -371x
PBR - - -
PEG - 0.4x 4.1x
Capitalization / Revenue 1.65x 1.28x 1.12x
EV / Revenue 1.52x 1.15x 0.97x
EV / EBITDA 73.3x 20x 13.6x
EV / EBIT 114x 25x 16.1x
EV / FCF -42.8x 14.3x 10.7x
FCF Yield -2.34% 7% 9.34%
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.2693 -0.0655 -0.0055
Distribution rate - - -
Net sales 1 33.7 43.35 49.8
EBITDA 1 0.7 2.5 3.55
EBIT 1 0.45 2 3
Net income 1 -5.9 -1.8 -0.1
Net Debt 1 -4.3 -5.65 -7.45
Reference price 2 2.040 2.040 2.040
Nbr of stocks (in thousands) 27,275 - -
Announcement Date - - -
1GBP in Million2GBP
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- 1.52x73.34x - 74.43M
21.24x5.79x12.51x2.05% 173B
13.18x3.26x - 2.68% 142B
15.57x7.18x - 1.59% 97.75B
19.64x7.06x12.58x4.31% 94.34B
14.41x9.79x16.77x0.86% 81.99B
22.23x11.69x19.1x4.26% 75.23B
18.22x10.47x8.06x1.98% 66.63B
12.48x4.8x - 2.09% 45.79B
Average 17.12x 6.84x 23.73x 2.48% 86.32B
Weighted average by Cap. 17.45x 6.99x 13.65x 2.47%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Molecule Group plc

Historical PBR trend

Valuation ratios - PBR - Molecule Group plc

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Molecule Group plc

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Molecule Group plc

  1. Stock Market
  2. Stocks
  3. MOL Stock
  4. Valuation Molecule Group plc